A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

PHASE2RecruitingINTERVENTIONAL

Enrollment

168

Participants

Timeline

Start Date

September 17, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions

Atopic Dermatitis of Adults

Interventions

DRUG

RSS0393 ointment

RSS0393 ointment 0.05%

DRUG

RSS0393 ointment

RSS0393 ointment 0.01%

DRUG

RSS0393 ointment

RSS0393 ointment 0.03%

DRUG

RSS0393 ointment

RSS0393 ointment placebo

Trial Locations (1)

RECRUITING

Dermatology Hospital of Southern Medical University, Guangzhou

All Listed Sponsors

lead

Reistone Biopharma Company Limited

INDUSTRY

NCT07158151 - A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis | Biotech Hunter | Biotech Hunter